Home LiteratureArticle Details
PMID: 8008747 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Prognosis of gastric carcinoma revealed by interactions between tumor cells and basement membrane.

Grigioni WF, D'Errico A, Fortunato C, Fiorentino M, Mancini AM, Stetler-Stevenson WG, Sobel ME, Liotta LA, Onisto M, Garbisa S

Abstract

The extra-cellular matrix (ECM) related antigens, type IV collagen, laminin, M(r) 68,000 laminin receptor (LR), M(r) 72,000 type IV collagenase (MMP-2), its inhibitor TIMP-2, and alpha 2-macroglobulin expression have been immunohistochemically investigated in 100 cases of human gastric carcinoma with a 5-yr follow up. Basement membranes were inversely related to tumoral differentiation. At the early intramucosal stage of both intestinal and diffuse histological types, TIMP-2 was expressed by the majority of tumor cells (60/63%), whereas MMP-2+ and LR+ cells were in the minority (24/19%, 23/0%, respectively). At the early submucosal stage, TIMP-2+ cells moderately decreased in both histological types (49/49%), whereas a consistently higher number of both MMP-2+ and LR+ cells were detected only in the diffuse carcinomas (72%). In the advanced stage, the expression of TIMP-2 further declined (22/24%), although the other two antigens increased or maintained high levels of expression. AMG+ cells never exceeded 10% in either histological type at any stage. In the liver metastases, both MMP-2+ and LR+ cells were more numerous than in the primary tumor (P < 0.002 and P < 0.01). Patients who died from their primary tumor had higher percentages of LR+, MMP-2+, and AMG+ cells and lower percentages of TIMP-2+ cells with respect to survivors. We believe evaluation of ECM-related antigens, and especially TIMP-2, may help determine a confident prognosis for gastric cancer.

MeSH Terms
Antineoplastic Agents/metabolism Basement Membrane Biomarkers, Tumor Carcinoma/metabolism,pathology Extracellular Matrix Proteins/metabolism Follow-Up Studies Gelatinases/metabolism Humans Immunoenzyme Techniques Matrix Metalloproteinase 2 Metalloendopeptidases/antagonists & inhibitors,metabolism Prognosis Proteins/metabolism Receptors, Laminin/metabolism Stomach Neoplasms/metabolism,pathology Survival Rate Tissue Inhibitor of Metalloproteinase-2
Chemicals
Antineoplastic Agents Biomarkers, Tumor Extracellular Matrix Proteins Proteins Receptors, Laminin Tissue Inhibitor of Metalloproteinase-2 Gelatinases Metalloendopeptidases Matrix Metalloproteinase 2
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Grigioni W F
Pathology Institute, Medical School of Bologna, Italy.
D'Errico A
Fortunato C
Fiorentino M
Mancini A M
Stetler-Stevenson W G
Sobel M E
Liotta L A
Onisto M
Garbisa S
Article Info
Journal
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Abbr.
Mod Pathol
ISSN
0893-3952
Published
1994-02-00
Pages
220-5
Language
English
Region
United States
NLM ID
8806605
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]